Physician profile
Grace H Chang
NPI 1639335029
$1,372.12
in general payments reported to CMS, 2019-2025
13 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $267 · 2021: $75.45 · 2022: $283 · 2023: $334 · 2024: $174 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $646.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $188.55 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Aroa Biosurgery Incorporated | $149.50 | 2024 | |
| Shockwave Medical, INC | $139.29 | 2025 | |
| Davol INC. | $138.03 | 2022 | |
| Kci USA, INC. | $137.72 | 2020-2021 | |
| Polynovo North America LLC | $131.80 | 2022 | |
| Acell, INC. | $124.24 | 2020 | |
| Teleflex LLC | $115.55 | 2023 | Quikclot |
| Merck Sharp & Dohme LLC | $87.14 | 2019 | |
| Ethicon US, LLC | $80.12 | 2020-2022 | |
| Stryker Corporation | $37.14 | 2023 | Pinpoint |
| Kls-Martin L.P. | $29.73 | 2019-2023 | |
| Cook Medical LLC | $13.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.